Why people stop GLP-1 treatment
People stop GLP-1 treatment for many reasons: side effects, cost, supply issues, routine drift, or simply losing momentum. Understanding the common patterns can help reduce avoidable discontinuation.
Why this matters
Discontinuation is one of the biggest challenges in GLP-1 treatment. The evidence suggests that stopping treatment often leads to weight regain, which can undo the health benefits achieved. Understanding why people stop is the first step towards reducing avoidable stops.
Common reasons people stop
Side effects
Nausea, gastrointestinal discomfort, and fatigue can make treatment feel unsustainable, especially during dose titration. Some people stop before their body has had time to adjust.
Cost and access
GLP-1 medicines can be expensive when funded privately. Supply shortages have also forced interruptions. When access is disrupted, restarting can feel difficult.
Routine drift
Travel, illness, stress, or changes in routine can lead to missed doses. A few missed doses can become a pattern, and re-engaging feels harder the longer the gap.
Loss of motivation
When weight loss slows or plateaus, the motivation that came with early results can fade. Without visible progress, the effort of maintaining treatment can feel less worthwhile.
Reaching a goal weight
Some people stop because they've reached their goal. Without a plan for what comes next, this can lead to regain. Maintenance after reaching a target weight still requires attention and support.
External pressure or stigma
Some people feel pressure to stop because of negative attitudes towards weight-loss medicines. This can lead to stopping without medical guidance.
How Healthcount helps
Healthcount is designed to catch drift early — before a missed dose becomes a pattern, before a routine slip becomes a stop. It uses low-burden signals to detect changes and suggests one practical next step at a time.
When the right next step is clinical — for example, if side effects are affecting adherence — Healthcount signposts clearly. It does not prescribe, diagnose, or advise dose changes.
Frequently asked questions
Reducing avoidable discontinuation
If you're an insurer or employer, contact us about a pilot.